Add like
Add dislike
Add to saved papers

Histopathological classification of cross-sectional image negative hyperaldosteronism.

CONTEXT: Approximately half of primary aldosteronism (PA) have clinically evident disease according to clinical (hypertension) and/or laboratory (aldosterone and renin levels) findings but do not have nodules detectable in routine cross-sectional imaging. However, the detailed histopathologic, steroidogenic and pathobiological features of cross-sectional image negative PA have not been well characterized.

OBJECTIVE: Examine histopathology, steroidogenic enzyme expression and somatic mutation status of aldosterone-driver genes in adrenals from cross-sectional image negative hyperaldosteronism.

METHODS: 25 cross-sectional image negative cases were retrospectively reviewed. In situ adrenal aldosterone production capacity was determined using immunohistochemistry (IHC) of steroidogenic enzymes. Somatic mutation status of aldosterone-driver genes (ATP1A1, ATP2B3, CACNA1D and KCNJ5) was determined in the CYP11B2 immunopositive areas (n=35, micronodule: n=32, ZG: n=3) using next-generation sequencing (NGS) after macrodissection.

RESULTS: 25 cases were classified as multiple adrenocortical micronodules (MN, n=13) or diffuse hyperplasia of zona glomerulosa (DH, n=12) based upon histopathological evaluation and CYP11B2 IHC. Somatic mutations in aldosterone-driver genes were detected in 21 of 26 (81%) of CYP11B2-positive cortical micronodules in MN, with 17 (65%) mutations in CACNA1D, two (8%) in KCNJ5, and one each (4% each) in ATP1A1 and ATP2B). One of six (17%) of nodules in DH harbored somatic aldosterone-driver gene mutations (in CACNA1D), however no mutations were detected in CYP11B2-positive non-nodular DH areas.

CONCLUSION: Morphologic evaluation and CYP11B2 IHC enabled the classification of cross-sectional image negative hyperaldosteronism into MN and DH. Somatic mutations driving renin-independent aldosterone production are common in micronodules of MN, suggesting the novel histological entity possibly related to APCC development.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app